Netzach
Forumer storico
On 7/1/09, Human Genome Sciences (NASDAQ:HGSI) announced that it expects to have top-line results available on 7/20/09 for BLISS-52, the first of two pivotal Phase 3 clinical trials of BENLYSTA in systemic lupus erythematosus (SLE). HGSI will host a conference call to discuss the results on 7/20/09 at 8:15 AM Eastern.
http://www.officialwire.com/main.php?action=posted_news&rid=6948&catid=159
http://www.officialwire.com/main.php?action=posted_news&rid=6948&catid=159